Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBrief Communication

Hepatic Artery Injection of 131I-Metuximab Combined with Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Prospective Nonrandomized, Multicenter Clinical Trial

Hui Chen, Gang Nan, Ding Wei, Ren-You Zhai, Ming Huang, Wu-Wei Yang, Bao-Cai Xing, Xu Zhu, Hai-Feng Xu, Xiao-Dong Wang, Xiao-Yong Zhang, Bao-Rang Zhu, Peng Liu, Guang Cao, Song Gao, Chun-Yi Hao, Ren-Jie Yang, Jian-Hai Guo, Xin Zhang, Kun Gao, Kun Wang, Jian-Feng Wang, Zi-Yu Li, Lin-Zhong Zhu, Rong Ding, Jing Li, Ling Zhao, Yu-Jun Shao, Hai-Chun Liu, Jie-Lai Xia, Ling Wang, Ling-Min Kong, Zhi-Nan Chen and Huijie Bian
Journal of Nuclear Medicine April 2022, 63 (4) 556-559; DOI: https://doi.org/10.2967/jnumed.121.262136
Hui Chen
1Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital, Beijing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gang Nan
2National Translational Science Center for Molecular Medicine and Department of Cell Biology, State Key Laboratory of Cancer Biology, Fourth Military Medical University, Xi’an, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ding Wei
2National Translational Science Center for Molecular Medicine and Department of Cell Biology, State Key Laboratory of Cancer Biology, Fourth Military Medical University, Xi’an, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ren-You Zhai
3Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ming Huang
4Yunnan Cancer Hospital, Third Affiliated Hospital of Kunming Medical University, Kunming, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wu-Wei Yang
5Fifth Medical Center, Chinese PLA General Hospital, Beijing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bao-Cai Xing
1Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital, Beijing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xu Zhu
1Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital, Beijing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hai-Feng Xu
1Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital, Beijing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiao-Dong Wang
1Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital, Beijing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiao-Yong Zhang
6China Nuclear Industry Beijing 401 Hospital, Beijing, China; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bao-Rang Zhu
5Fifth Medical Center, Chinese PLA General Hospital, Beijing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peng Liu
1Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital, Beijing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guang Cao
1Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital, Beijing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Song Gao
1Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital, Beijing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chun-Yi Hao
1Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital, Beijing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ren-Jie Yang
1Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital, Beijing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jian-Hai Guo
1Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital, Beijing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xin Zhang
1Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital, Beijing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kun Gao
3Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kun Wang
1Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital, Beijing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jian-Feng Wang
3Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zi-Yu Li
1Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital, Beijing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lin-Zhong Zhu
1Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital, Beijing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rong Ding
4Yunnan Cancer Hospital, Third Affiliated Hospital of Kunming Medical University, Kunming, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jing Li
5Fifth Medical Center, Chinese PLA General Hospital, Beijing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ling Zhao
4Yunnan Cancer Hospital, Third Affiliated Hospital of Kunming Medical University, Kunming, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yu-Jun Shao
6China Nuclear Industry Beijing 401 Hospital, Beijing, China; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hai-Chun Liu
6China Nuclear Industry Beijing 401 Hospital, Beijing, China; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jie-Lai Xia
7College of Military Preventive Medicine, Fourth Military Medical University, Xi’an, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ling Wang
7College of Military Preventive Medicine, Fourth Military Medical University, Xi’an, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ling-Min Kong
2National Translational Science Center for Molecular Medicine and Department of Cell Biology, State Key Laboratory of Cancer Biology, Fourth Military Medical University, Xi’an, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhi-Nan Chen
2National Translational Science Center for Molecular Medicine and Department of Cell Biology, State Key Laboratory of Cancer Biology, Fourth Military Medical University, Xi’an, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Huijie Bian
2National Translational Science Center for Molecular Medicine and Department of Cell Biology, State Key Laboratory of Cancer Biology, Fourth Military Medical University, Xi’an, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 63 no. 4 556-559
DOI 
https://doi.org/10.2967/jnumed.121.262136
PubMed 
34475235

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication February 22, 2021
  • Revision received July 15, 2021
  • Published online March 31, 2022.

Article Versions

  • previous version (September 2, 2021 - 13:01).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2022 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Hui Chen*,1,
  2. Gang Nan*,2,
  3. Ding Wei2,
  4. Ren-You Zhai3,
  5. Ming Huang4,
  6. Wu-Wei Yang5,
  7. Bao-Cai Xing1,
  8. Xu Zhu1,
  9. Hai-Feng Xu1,
  10. Xiao-Dong Wang1,
  11. Xiao-Yong Zhang6,
  12. Bao-Rang Zhu5,
  13. Peng Liu1,
  14. Guang Cao1,
  15. Song Gao1,
  16. Chun-Yi Hao1,
  17. Ren-Jie Yang1,
  18. Jian-Hai Guo1,
  19. Xin Zhang1,
  20. Kun Gao3,
  21. Kun Wang1,
  22. Jian-Feng Wang3,
  23. Zi-Yu Li1,
  24. Lin-Zhong Zhu1,
  25. Rong Ding4,
  26. Jing Li5,
  27. Ling Zhao4,
  28. Yu-Jun Shao6,
  29. Hai-Chun Liu6,
  30. Jie-Lai Xia7,
  31. Ling Wang7,
  32. Ling-Min Kong2,
  33. Zhi-Nan Chen2 and
  34. Huijie Bian2
  1. 1Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital, Beijing, China;
  2. 2National Translational Science Center for Molecular Medicine and Department of Cell Biology, State Key Laboratory of Cancer Biology, Fourth Military Medical University, Xi’an, China;
  3. 3Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China;
  4. 4Yunnan Cancer Hospital, Third Affiliated Hospital of Kunming Medical University, Kunming, China;
  5. 5Fifth Medical Center, Chinese PLA General Hospital, Beijing, China;
  6. 6China Nuclear Industry Beijing 401 Hospital, Beijing, China; and
  7. 7College of Military Preventive Medicine, Fourth Military Medical University, Xi’an, China
  1. For correspondence or reprints, contact Huijie Bian (hjbian{at}fmmu.edu.cn) or Zhi-Nan Chen (znchen{at}fmmu.edu.cn).
  1. ↵* Contributed equally to this work.

View Full Text

Statistics from Altmetric.com

Cited By...

  • 10 Citations
  • 11 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • The Synergistic Effect of Interventional Locoregional Treatments and Immunotherapy for the Treatment of Hepatocellular Carcinoma
    Nicolò Brandi, Matteo Renzulli
    International Journal of Molecular Sciences 2023 24 10
  • Recent Advances in Locoregional Therapy of Hepatocellular Carcinoma
    Anna Podlasek, Maheeba Abdulla, Dieter Broering, Khalid Bzeizi
    Cancers 2023 15 13
  • One-step synthesis of a radioiodinated anti-microRNA-21 oligonucleotide for theranostics in prostate tumor xenografts
    Shaozhong Xian, Zhao Chen, Wenpeng Huang, Lingna Zhao, Yongkang Qiu, Pan Hao, Lixin Sun, Qi Yang, Lele Song, Lei Kang
    Colloids and Surfaces A: Physicochemical and Engineering Aspects 2022 649
  • Functional Imaging of Liver Cancer (FLIC): Study protocol of a phase 2 trial of 18F-DCFPyL PET/CT imaging for patients with hepatocellular carcinoma
    Esther Mena, Joanna Shih, Joon-Yong Chung, Jennifer Jones, Atoosa Rabiee, Cecilia Monge, Baris Turkbey, Liza Lindenberg, Kilian E. Salerno, Michael Kassin, Brad Wood, Jonathan Hernandez, Roberto Maass-Moreno, Babak Saboury, Neha Jakhete, Jason K. Molitoris, Keith R. Unger, Peter L. Choyke, Freddy E. Escorcia, Johannes Stortz
    PLOS ONE 2022 17 11
  • 124I-labeled anti-CD147 antibody for noninvasive detection of CD147-positive pan-cancers: construction and preclinical studies
    Xiao-kun Ma, Te-li Liu, Ya-nan Ren, Xiao-pan Ma, Yuan Yao, Xing-guo Hou, Jin Ding, Feng Wang, Hai-feng Huang, Hua Zhu, Zhi Yang
    Acta Pharmacologica Sinica 2024 45 2
  • Analysis of factors influencing the distribution of 131-I in combined treatment of Licartin with transcatheter arterial chemoembolization in primary hepatic carcinoma
    Ming Tang, Wen-Liang Li, Jia-Yu Li, Juan Lv, Fu-Kun Chen, Jia-Lun Zhu, Peng-Jie Liu
    Frontiers in Oncology 2023 12
  • Site-Specific Radioiodination of Oligonucleotides with a Phenolic Element in a Programmable Approach
    Haitao Zhao, Yu Qin, Dunfang Liu, Xinyao Geng, Cheng Wang, Ding Ding, Xuan Ding, Qian Xia, Jianjun Liu, Ruowen Wang, Weihong Tan
    Molecules 2022 27 19
  • The inhibiting effect of alpha-based TARE on embolized vessels and neovascularization
    Qianqian Tong, Rou Li, Ruizhi Wang, Changjing Zuo, Danni Li, Guorong Jia, Ye Peng, Xiaohong Li, Jian Yang, Shuai Xue, Qingyun Bai, Xiao Li
    Frontiers in Bioengineering and Biotechnology 2022 10
  • Prostate-specific membrane antigen-targeting radiopharmaceuticals: a new frontier in hepatic malignancies
    Fucen Liu, Liming Xiao, Ling Zhao, Yi Tao, Dan Huang, Zhengguo Chen, Chuandong He, Chunyan Wu
    Frontiers in Oncology 2025 15
  • Reference Module in Chemistry, Molecular Sciences and Chemical Engineering
    Nicolas Lepareur
    2025

Article usage

Article usage: September 2021 to April 2025

AbstractFullPdf
Sep 20211569026
Oct 2021484011
Nov 2021480012
Dec 202134106
Jan 202221703
Feb 202220904
Mar 20221823141
Apr 2022600397112
May 202231310166
Jun 2022420428
Jul 2022438013
Aug 202224336
Sep 2022429627
Oct 20223027648
Nov 20224111246
Dec 20223339235
Jan 20233239429
Feb 20231636634
Mar 20232637340
Apr 20231927514
May 2023919724
Jun 2023523516
Jul 2023920024
Aug 20231133222
Sep 20231425613
Oct 2023310920
Nov 202397814
Dec 202336734
Jan 20241615528
Feb 2024718317
Mar 2024812653
Apr 20241411840
May 2024134719
Jun 2024189136
Jul 20241010235
Aug 202485424
Sep 2024112422
Oct 2024112520
Nov 2024142221
Dec 202463722
Jan 202574130
Feb 2025136218
Mar 202596131
Apr 2025134341
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 63 (4)
Journal of Nuclear Medicine
Vol. 63, Issue 4
April 1, 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Hepatic Artery Injection of 131I-Metuximab Combined with Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Prospective Nonrandomized, Multicenter Clinical Trial
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Hepatic Artery Injection of 131I-Metuximab Combined with Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Prospective Nonrandomized, Multicenter Clinical Trial
Hui Chen, Gang Nan, Ding Wei, Ren-You Zhai, Ming Huang, Wu-Wei Yang, Bao-Cai Xing, Xu Zhu, Hai-Feng Xu, Xiao-Dong Wang, Xiao-Yong Zhang, Bao-Rang Zhu, Peng Liu, Guang Cao, Song Gao, Chun-Yi Hao, Ren-Jie Yang, Jian-Hai Guo, Xin Zhang, Kun Gao, Kun Wang, Jian-Feng Wang, Zi-Yu Li, Lin-Zhong Zhu, Rong Ding, Jing Li, Ling Zhao, Yu-Jun Shao, Hai-Chun Liu, Jie-Lai Xia, Ling Wang, Ling-Min Kong, Zhi-Nan Chen, Huijie Bian
Journal of Nuclear Medicine Apr 2022, 63 (4) 556-559; DOI: 10.2967/jnumed.121.262136

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Hepatic Artery Injection of 131I-Metuximab Combined with Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Prospective Nonrandomized, Multicenter Clinical Trial
Hui Chen, Gang Nan, Ding Wei, Ren-You Zhai, Ming Huang, Wu-Wei Yang, Bao-Cai Xing, Xu Zhu, Hai-Feng Xu, Xiao-Dong Wang, Xiao-Yong Zhang, Bao-Rang Zhu, Peng Liu, Guang Cao, Song Gao, Chun-Yi Hao, Ren-Jie Yang, Jian-Hai Guo, Xin Zhang, Kun Gao, Kun Wang, Jian-Feng Wang, Zi-Yu Li, Lin-Zhong Zhu, Rong Ding, Jing Li, Ling Zhao, Yu-Jun Shao, Hai-Chun Liu, Jie-Lai Xia, Ling Wang, Ling-Min Kong, Zhi-Nan Chen, Huijie Bian
Journal of Nuclear Medicine Apr 2022, 63 (4) 556-559; DOI: 10.2967/jnumed.121.262136
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Feasibility of an Ultra-Low-Dose PET Scan Protocol with CT-Based and LSO-TX–Based Attenuation Correction Using a Long–Axial-Field-of-View PET/CT Scanner
  • Prostate Cancer Recurrence Due to Isolated Testicular Metastases Detected by PSMA PET/CT
  • First-in-Human Serum Stability Studies of [177Lu]Lu-AMTG: A Step Toward Improved GRPR-Targeted Radiopharmaceutical Therapy
Show more BRIEF COMMUNICATION

Similar Articles

Keywords

  • 131I-labeled metuximab
  • transcatheter arterial chemoembolization
  • hepatocellular carcinoma
SNMMI

© 2025 SNMMI

Powered by HighWire